Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 31

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 31
---
 medical insurance benefits and employer contributions to the Named Executive Officer’s 401k benefit plan accounts.                       |

Employment Agreements

We have not entered into employment agreements with either of our named executive officers. Each of Dr. Kumar and Mr. Catelani are engaged as at-will employees of the Company.

Stock Options

Outstanding Stock Option Awards

| 18 |

The following table sets forth certain information with respect to unexercised stock options held by the Named Executive Officers outstanding on October 31, 2024:

| OUTSTANDING OPTION AWARDS 
 Name                      |     | Number of   
 Securities  
 Underlying  
 Unexercised 
 Options (#) 
 Exercisable |           |    |     | Number of      
 Securities     
 Underlying     
 Unexercised    
 Options (#)    
 Un-Exercisable |           |    |     | Option Exercise Price ($) |      |     | Option          
 Expiration Date |
|:--------------------------|:----|:------------|----------:|---:|:----|:---------------|----------:|---:|:----|:--------------------------|-----:|:----|:----------------|
| Dr. Amit Kumar            |     |             |   200,000 |    |     |                |           |    |     | $                         | 2.92 |     | 2/18/2026       |
|                           |     |             |   600,000 |    |     |                |           |    |     | $                         | 3.70 |     | 5/8/2028        |
|                           |     |             |   500,000 |    |     |                |           |    |     | $                         | 3.70 |     | 5/8/2028        |
|                           |     |             |   520,000 |    |     |                |           |    |     | $                         | 3.84 |     | 12/12/2029      |
|                           |     |             | 1,000,000 |    |     |                |           |    |     | $                         | 2.83 |     | 12/23/2030      |
|                           |     |             |   500,000 |    |     |                |           |    |     | $                         | 4.02 |     | 6/1/2031        |
|                           |     |